Epidemiology and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong

Journal of Hospital Infection

Volumn 74, Issue 4, 2010, Pages 358-364

  Ho, P L ^a   Ho, A Y ^a   Chow, K H ^a   Lai, E L ^a   Ching, P ^b   Seto, W H ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Acinetobacter baumannii; Molecular epidemiology; Multilocus sequence typing; Risk factors

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; MINOCYCLINE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHRONIC WOUND; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE IDENTIFICATION; HEALTH CARE; HONG KONG; HUMAN; MALE; MICROBIAL COLONIZATION; MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII INFECTION; PHENOTYPE; BACTERIUM IDENTIFICATION; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; DRUG EFFECT; GENETICS; HEALTH CARE FACILITY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; WOUND INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HEALTH FACILITIES; HONG KONG; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; WOUND INFECTION;

EID: 77952580158     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.10.015     Document Type: Article

References (27)

1. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
2. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
3. Tsakris A., Ikonomidis A., Pournaras S., et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis 2006, 12:981-983.
4. Siau H., Yuen K.Y., Wong S.S., Ho P.L., Luk W.K. The epidemiology of acinetobacter infections in Hong Kong. J Med Microbiol 1996, 44:340-347.
5. Falagas M.E., Koletsi P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006, 55:1619-1629.
6. Harris A.D., Karchmer T.B., Carmeli Y., Samore M.H. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001, 32:1055-1061.
7. Ho P.L., Tse W.S., Tsang K.W., et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 2001, 32:701-707.
8. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
9. Siau H., Yuen K.Y., Ho P.L., et al. Identification of acinetobacters on blood agar in presence of d-glucose by unique browning effect. J Clin Microbiol 1998, 36:1404-1407.
10. Vaneechoutte M., Dijkshoorn L., Tjernberg I., et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995, 33:11-15.
11. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement 2007, CLSI, Wayne, PA.
12. Seifert H., Dolzani L., Bressan R., et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4328-4335.
13. Bartual S.G., Seifert H., Hippler C., Luzon M.A., Wisplinghoff H., Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4382-4390.
14. Huys G., Cnockaert M., Nemec A., Swings J. Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2005, 43:5327-5331.
15. Yong D., Lee K., Yum J.H., Shin H.B., Rossolini G.M., Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002, 40:3798-3801.
16. Franklin C., Liolios L., Peleg A.Y. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006, 44:3139-3144.
17. Mendes R.E., Kiyota K.A., Monteiro J., et al. Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 2007, 45:544-547.
18. Woodford N., Ellington M.J., Coelho J.M., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
19. Koh T.H., Sng L.H., Wang G.C., Hsu L.Y., Zhao Y. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 2007, 59:627-632.
20. Zhou H., Yang Q., Yu Y.S., Wei Z.Q., Li L.J. Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China. J Clin Microbiol 2007, 45:4054-4057.
21. Ho P.L., Chan W.M., Tsang K.W., Wong S.S., Young K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 2002, 34:567-573.
22. Ho P.L., Poon W.W., Loke S.L., et al. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 2007, 60:140-144.
23. Curcio D., Fernandez F. Comment on: effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp. J Antimicrob Chemother 2008, 62:1166-1167.
24. Jones R.N., Ferraro M.J., Reller L.B., Schreckenberger P.C., Swenson J.M., Sader H.S. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007, 45:227-230.
25. Navon-Venezia S., Leavitt A., Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007, 59:772-774.
26. Pillar C.M., Draghi D.C., Dowzicky M.J., Sahm D.F. In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest. J Clin Microbiol 2008, 46:2862-2867.
27. Thamlikitkul V., Tiengrim S., Tribuddharat C. Comment on: high tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007, 60:177-178.